3 completed, 1 unknown, 1 withdrawn. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Withdrawn 1 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
Follow Cytarabine Hydrochloride: new trials by email Literature Review of Cytarabine Hydrochloride trials Research Report on Cytarabine Hydrochloride
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Bisantrene Combined With Cytarabine or With Decitabine for Adult Subjects With Extramedullary AML and MDS Bisantrene Dihydrochloride (high dose), Bisantrene Dihydrochloride (low dose), Cytarabine Hydrochloride - Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia | Phase 1 | Withdrawn | Racura Oncology Ltd | 2022-07-29 | 2023-10-03 | |
| Efficacy and Safety of Cladribine in Combination With CAG in Newly Diagnosed Unfit Patients With AML Cladribine Injection, Aclarubicin, G-CSF - Acute Myeloid Leukemia, Elderly Patients | Phase 2 | Unknown | Sun Yat-sen University | 34 | 2021-03-01 | 2020-12-17 |
| Trial Testing Safety of IL-21 NK Cells for Induction of R/R AML Cytarabine Hydrochloride, Fludarabine, Membrane-bound Interleukin-21-Expanded Haploidentical Natural Killer Cells - Allogeneic Stem Cell Transplant Recipient, Blasts 10 Percent or More of Bone Marrow Nucleated Cells | Phase 1 | Completed | Sumithira Vasu | 19 | 2020-06-11 | 2026-01-09 |
| A Study to Assess AC220 Given in Combination With Induction and Consolidation Therapy in Newly Diagnosed Acute Myeloid Leukemia (AML) AC220, daunorubicin, cytarabine - Leukemia, Myeloid, Acute | Phase 1 | Completed | Daiichi Sankyo | 19 | 2011-10-01 | 2019-02-12 |
| Chemotherapy Combined With Radiation Therapy for Newly Diagnosed CNS AT/RT filgrastim, cisplatin, cyclophosphamide - Central Nervous System Tumor, Pediatric | Phase 2 | Completed | Dana-Farber Cancer Institute | 25 | 2003-02-01 | 2015-12-24 |
Leukemia, Myeloid, Acute (4) · Central Nervous System Neoplasms (1) · Leukemia, Myelomonocytic, Chronic (1) · Myelodysplastic Syndromes (1) · Rhabdoid Tumor (1)
Daiichi Sankyo (1) · Dana-Farber Cancer Institute (1) · Racura Oncology Ltd (1) · Sumithira Vasu (1) · Sun Yat-sen University (1)
United States (3) · Australia (1) · China (1)
Guy Gammon, MB, BS, MRCP (1) · Marinella Messina, PhD (1) · Mark W. Kieran, MD, PhD (1) · Sumithira Vasu, MBBS (1)
P30CA006516 (1)